FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Vahram Haroutunian

Research Profile

Disorders

Anatomy

Living Beings

Rats
Mouse

Chemicals & Drugs

Physiology

Co-author Network

Publications

TOP 3
Jana B Drummond; Vahram Haroutunian; Janusz Tucholski; James Meador-Woodruff
Transmembrane AMPA receptor regulatory protein (TARP) dysregulation in anterior cingulate cortex in schizophrenia.
Janusz Tucholski; Vahram Haroutunian; Robert E McCullumsmith; Anita L Pinner; Micah S Simmons; James H Meador-Woodruff
Abnormal N-linked glycosylation of cortical AMPA receptor subunits in schizophrenia.
Sam Gandy; Vahram Haroutunian; Mary Sano; Steven T DeKosky; Eric E Schadt
CR1 and the "vanishing amyloid" hypothesis of Alzheimer's disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Vahram Haroutunian (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jana B Drummond; Vahram Haroutunian; Janusz Tucholski; James Meador-Woodruff
Transmembrane AMPA receptor regulatory protein (TARP) dysregulation in anterior cingulate cortex in schizophrenia.
Schizophrenia research 2013;147(1):32-8.
2013: Janusz Tucholski; Vahram Haroutunian; Robert E McCullumsmith; Anita L Pinner; Micah S Simmons; James H Meador-Woodruff
Abnormal N-linked glycosylation of cortical AMPA receptor subunits in schizophrenia.
Schizophrenia research 2013;146(1-3):177-83.
2013: Sam Gandy; Vahram Haroutunian; Mary Sano; Steven T DeKosky; Eric E Schadt
CR1 and the "vanishing amyloid" hypothesis of Alzheimer's disease.
Biological psychiatry 2013;73(5):393-5.
2013: Dan Shan; James Meador-Woodruff; Jana B Drummond; Vahram Haroutunian; Elizabeth K Lucas; Robert E McCullumsmith
Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia.
Schizophrenia research 2013;144(1-3):1-8.
2013: Panos Roussos; Larry J Siever; Todd Lencz; Anil K Malhotra; Panos Bitsios; Kenneth L Davis; Stella G Giakoumaki; Pavel Katsel; Vahram Haroutunian
Convergent findings for abnormalities of the NF-κB signaling pathway in schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2013;38(3):533-9.
2013: Wei Zhao; Merina Varghese; Shrishailam Yemul; Kristen Dams-O'Connor; Daniel Freire; Wayne Gordon; Vahram Haroutunian; Lap Ho; Lindsay Knable; Giulio Maria Pasinetti
Decreased level of olfactory receptors in blood cells following traumatic brain injury and potential association with tauopathy.
Journal of Alzheimer's disease : JAD 2013;34(2):417-29.
2012: Jana B Drummond; Vahram Haroutunian; Micah Simmons; James H Meador-Woodruff
Upregulation of cornichon transcripts in the dorsolateral prefrontal cortex in schizophrenia.
Neuroreport 2012;23(17):1031-4.
2012: Panos Roussos; Larry J Siever; Kenneth L Davis; Pavel Katsel; Vahram Haroutunian
A system-level transcriptomic analysis of schizophrenia using postmortem brain tissue samples.
Archives of general psychiatry 2012;69(12):1205-13.
2012: Jeremy M Silverman; Rebecca West; Clive Rosendorff; Mary Sano; James Schmeidler; Michal Schnaider Beeri; Irina N Bespalova; José R Carrión-Baralt; Hillel T Grossman; Vahram Haroutunian
C-reactive protein and familial risk for dementia: a phenotype for successful cognitive aging.
Neurology 2012;79(11):1116-23.
2012: Bertan Hallacoglu; Vahram Haroutunian; Irwin H Rosenberg; Angelo Sassaroli; Michal Schnaider Beeri; Merav Shaul; Aron M Troen; Michael Wysocki; Elizabeth Guerrero-Berroa; Sergio Fantini
Absolute measurement of cerebral optical coefficients, hemoglobin concentration and oxygen saturation in old and young adults with near-infrared spectroscopy.
Journal of biomedical optics 2012;17(8):081406-1.
2012: Michal Schnaider Beeri; Gerson T Lesser; Stephanie Leung; Maria Maroukian; Daniel P Perl; Dushyant P Purohit; James Schmeidler; Rebecca West; Michael Wysocki; Vahram Haroutunian
Corticosteroids, but not NSAIDs, are associated with less Alzheimer neuropathology.
Neurobiology of aging 2012;33(7):1258-64.
2012: Michal Schnaider Beeri; Aaron Kavanaugh; Mary Sano; James Schmeidler; Alasdair M Barr; Peter Fam; Vahram Haroutunian; William G Honer; Pavel Katsel
Synaptic protein deficits are associated with dementia irrespective of extreme old age.
Neurobiology of aging 2012;33(6):1125.e1-8.
2012: María D Rubio; Vahram Haroutunian; James H Meador-Woodruff
Abnormalities of the Duo/Ras-related C3 botulinum toxin substrate 1/p21-activated kinase 1 pathway drive myosin light chain phosphorylation in frontal cortex in schizophrenia.
Biological psychiatry 2012;71(10):906-14.
2012: Dan Shan; James H Meador-Woodruff; Vahram Haroutunian; Robert E McCullumsmith
Expression of equilibrative nucleoside transporter type 1 protein in elderly patients with schizophrenia.
Neuroreport 2012;23(4):224-7.
2012: Mark S Moehle; James H Meador-Woodruff; Vahram Haroutunian; Richard Luduena; Robert E McCullumsmith
Regional differences in expression of β-tubulin isoforms in schizophrenia.
Schizophrenia research 2012;135(1-3):181-6.
2012: Adam J Funk; Vahram Haroutunian; Robert E McCullumsmith; James H Meador-Woodruff
Abnormal activity of the MAPK- and cAMP-associated signaling pathways in frontal cortical areas in postmortem brain in schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2012;37(4):896-905.
2012: Afia Akram; Patrick R Hof; Pavel Katsel; James Schmeidler; Vahram Haroutunian
Association of ApoE and LRP mRNA levels with dementia and AD neuropathology.
Neurobiology of aging 2012;33(3):628.e1-628.e14.
2012: Michael Wysocki; Karen Dahlman; Hillel Grossman; Vahram Haroutunian; Gerson T Lesser; Xiaodong Luo; James Schmeidler; Michal Schnaider Beeri
Hypertension is associated with cognitive decline in elderly people at high risk for dementia.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2012;20(2):179-87.
2012: John C Hammond; Vahram Haroutunian; James H Meador-Woodruff; Robert E McCullumsmith
AMPA receptor subunit expression in the endoplasmic reticulum in frontal cortex of elderly patients with schizophrenia.
PloS one 2012;7(6):e39190.
2012: Lap Ho; Pavel Katsel; Lindsay Knable; Shrishailam Yemul; Rudy Zhao; Vahram Haroutunian; Giulio Maria Pasinetti
Insulin receptor expression and activity in the brains of nondiabetic sporadic Alzheimer's disease cases.
International journal of Alzheimer's disease 2012;2012():321280.
2012: Lap Ho; Kristen Dams-O'Connor; Wayne Gordon; Vahram Haroutunian; Elaine R Peskind; Cheuk Y Tang; Shrishailam Yemul; Wei Zhao; Giulio Maria Pasinetti
Elevated plasma MCP-1 concentration following traumatic brain injury as a potential "predisposition" factor associated with an increased risk for subsequent development of Alzheimer's disease.
Journal of Alzheimer's disease : JAD 2012;31(2):301-13.
2012: Ramit Ravona-Springer; James Schmeidler; Jeremy M Silverman; Michael Wysocki; James Godbold; Hillel T Grossman; Vahram Haroutunian; Erin Moshier; Michael A Rapp; Jimmy Akrivos; Michal Schnaider Beeri
Changes in glycemic control are associated with changes in cognition in non-diabetic elderly.
Journal of Alzheimer's disease : JAD 2012;30(2):299-309.
2011: Ramit Ravona-Springer; James Schmeidler; Michael Wysocki; Karen Dahlman; Hillel T Grossman; Vahram Haroutunian; Gerson T Lesser; Xiaodong Luo; Michael A Rapp; Michal Schnaider Beeri
The association of age with rate of cognitive decline in elderly individuals residing in supporting care facilities.
Alzheimer disease and associated disorders 2011;25(4):312-6.
2011: Monsheel Sodhi; Micah Simmons; Vahram Haroutunian; Robert McCullumsmith; James Meador-Woodruff
Glutamatergic gene expression is specifically reduced in thalamocortical projecting relay neurons in schizophrenia.
Biological psychiatry 2011;70(7):646-54.
2011: Pavel Katsel; Mikhail V Pletnikov; Christopher A Ross; Weilun Tan; Bagrat Abazyan; Kenneth L Davis; Vahram Haroutunian
Expression of mutant human DISC1 in mice supports abnormalities in differentiation of oligodendrocytes.
Schizophrenia research 2011;130(1-3):238-49.
2011: John C Hammond; Vahram Haroutunian; Robert E McCullumsmith; James Meador-Woodruff
Endosomal trafficking of AMPA receptors in frontal cortex of elderly patients with schizophrenia.
Schizophrenia research 2011;130(1-3):260-5.
2011: Pavel Katsel; William Byne; Panos Roussos; Weilun Tan; Larry Siever; Vahram Haroutunian
Astrocyte and glutamate markers in the superficial, deep, and white matter layers of the anterior cingulate gyrus in schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2011;36(6):1171-7.
2011: Michael A Rapp; Michal Schnaider Beeri; Michael Wysocki; Elizabeth Guerrero-Berroa; Hillel T Grossman; Andreas Heinz; Vahram Haroutunian
Cognitive decline in patients with dementia as a function of depression.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2011;19(4):357-63.
2011: Y Horesh; Pavel Katsel; Vahram Haroutunian; E Domany
Gene expression signature is shared by patients with Alzheimer's disease and schizophrenia at the superior temporal gyrus.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2011;18(3):410-24.
2011: Amy Deep-Soboslay; Francine M Benes; Vahram Haroutunian; Justin K Ellis; Joel E Kleinman; Thomas M Hyde
Psychiatric brain banking: three perspectives on current trends and future directions.
Biological psychiatry 2011;69(2):104-12.
2011: Haiyun Xu; George Bartzokis; Vahram Haroutunian; Martha Elizabeth Shenton
Oligodendrocytes in schizophrenia.
Schizophrenia research and treatment 2011;2011():249768.
2011: Aurelian Radu; Gabriela Hristescu; Pavel Katsel; Vahram Haroutunian; Kenneth L Davis
Microarray database mining and cell differentiation defects in schizophrenia.
Advances in experimental medicine and biology 2011;696():67-74.
2010: Rebecca Lyddon; Edwin Cuppen; Vahram Haroutunian; Larry J Siever; Stella Dracheva
No link of serotonin 2C receptor editing to serotonin transporter genotype.
Neuroreport 2010;21(17):1080-4.
2010: Bing Gong; Fei Chen; Yong Pan; Isabel Arrieta-Cruz; Yukiko Yoshida; Vahram Haroutunian; Giulio M Pasinetti
SCFFbx2-E3-ligase-mediated degradation of BACE1 attenuates Alzheimer's disease amyloidosis and improves synaptic function.
Aging cell 2010;9(6):1018-31.
2010: Sang-Won Min; Seo-Hyun Cho; Yungui Zhou; Sebastian Schroeder; Vahram Haroutunian; William W Seeley; Eric J Huang; Yong Shen; Eliezer Masliah; Chandrani Mukherjee; DAVID MEYERS; Philip A Cole; Melanie Ott; Li Gan
Acetylation of tau inhibits its degradation and contributes to tauopathy.
Neuron 2010;67(6):953-66.
2010: Adam C Naj; Gary Beecham; Eden R Martin; Paul J Gallins; Eric Halsey Powell; Ioanna Konidari; Patrice L Whitehead; Guiqing Cai; Vahram Haroutunian; William Scott; Jeffery Vance; Michael Slifer; Harry E Gwirtsman; John Gilbert; Jonathan L Haines; Joseph Buxbaum; Margaret Pericak-Vance
Dementia revealed: novel chromosome 6 locus for late-onset Alzheimer disease provides genetic evidence for folate-pathway abnormalities.
PLoS genetics 2010;6(9):.
2010: John C Hammond; Robert E McCullumsmith; Adam J Funk; Vahram Haroutunian; James Meador-Woodruff
Evidence for abnormal forward trafficking of AMPA receptors in frontal cortex of elderly patients with schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2010;35(10):2110-9.
2010: David Kerns; Ghe S Vong; Kevin Barley; Stella Dracheva; Pavel Katsel; Patrizia Casaccia; Vahram Haroutunian; William Byne
Gene expression abnormalities and oligodendrocyte deficits in the internal capsule in schizophrenia.
Schizophrenia research 2010;120(1-3):150-8.
2010: Lars V Kristiansen; Sagar A Patel; Vahram Haroutunian; James Meador-Woodruff
Expression of the NR2B-NMDA receptor subunit and its Tbr-1/CINAP regulatory proteins in postmortem brain suggest altered receptor processing in schizophrenia.
Synapse (New York, N.Y.) 2010;64(7):495-502.
2010: Lars V Kristiansen; B Bakir; Vahram Haroutunian; James Meador-Woodruff
Expression of the NR2B-NMDA receptor trafficking complex in prefrontal cortex from a group of elderly patients with schizophrenia.
Schizophrenia research 2010;119(1-3):198-209.
2010: Pradeep Kurup; Yongfang Zhang; Jian Xu; Deepa V Venkitaramani; Vahram Haroutunian; Paul Greengard; Angus Nairn; Paul J Lombroso
Abeta-mediated NMDA receptor endocytosis in Alzheimer's disease involves ubiquitination of the tyrosine phosphatase STEP61.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2010;30(17):5948-57.
2010: Afia Akram; James Schmeidler; Pavel Katsel; Patrick R Hof; Vahram Haroutunian
Increased expression of cholesterol transporter ABCA1 is highly correlated with severity of dementia in AD hippocampus.
Brain research 2010;1318():167-77.
2010: Deborah Bauer; Vahram Haroutunian; James Meador-Woodruff; Robert E McCullumsmith
Abnormal glycosylation of EAAT1 and EAAT2 in prefrontal cortex of elderly patients with schizophrenia.
Schizophrenia research 2010;117(1):92-8.
2010: Afia Akram; James Schmeidler; Pavel Katsel; Patrick R Hof; Vahram Haroutunian
Increased expression of RXRα in dementia: an early harbinger for the cholesterol dyshomeostasis?
Molecular neurodegeneration 2010;5():36.
2010: Yuji Kajiwara; Sonia Franciosi; Nagahide Takahashi; Lisa Krug; James Schmeidler; Kevin Taddei; Vahram Haroutunian; Ulrik Fried; Michelle Ehrlich; Ralph N Martins; Sam Gandy; Joseph Buxbaum
Extensive proteomic screening identifies the obesity-related NYGGF4 protein as a novel LRP1-interactor, showing reduced expression in early Alzheimer's disease.
Molecular neurodegeneration 2010;5():1.
2010: Ramit Ravona-Springer; Xiaodong Luo; James Schmeidler; Michael Wysocki; Gerson Lesser; Michael A Rapp; Karen Dahlman; Hillel Grossman; Vahram Haroutunian; Michal Schnaider Beeri
Diabetes is associated with increased rate of cognitive decline in questionably demented elderly.
Dementia and geriatric cognitive disorders 2010;29(1):68-74.
2010: Michael A Rapp; Michal Schnaider Beeri; Dushyant P Purohit; Abraham Reichenberg; Susan R McGurk; Vahram Haroutunian; Philip D Harvey
Cortical neuritic plaques and hippocampal neurofibrillary tangles are related to dementia severity in elderly schizophrenia patients.
Schizophrenia research 2010;116(1):90-6.
2009: Elizabeth Guerrero-Berroa; Xiaodong Luo; James Schmeidler; Michael A Rapp; Karen Dahlman; Hillel T Grossman; Vahram Haroutunian; Michal Schnaider Beeri
The MMSE orientation for time domain is a strong predictor of subsequent cognitive decline in the elderly.
International journal of geriatric psychiatry 2009;24(12):1429-37.
2009: Michal Schnaider Beeri; James Schmeidler; Vahram Haroutunian; Rebecca West; Doris Ostad; Hillel T Grossman; Clive Rosendorff; Jeremy M Silverman
Better cognitive performance associated with worse cardiac functioning suggests antagonistic pleiotropy in very elderly subjects.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2009;17(10):911-2.
2009: Leslie S Libow; Pasquale G Frisina; Vahram Haroutunian; Daniel P Perl; Dushyant P Purohit
Parkinson's disease dementia: a diminished role for the Lewy body.
Parkinsonism & related disorders 2009;15(8):572-5.
2009: Michal Schnaider Beeri; Michael A Rapp; James Schmeidler; Abraham Reichenberg; Dushyant P Purohit; Daniel P Perl; Hillel T Grossman; Isak Prohovnik; Vahram Haroutunian; Jeremy Silverman
Number of children is associated with neuropathology of Alzheimer's disease in women.
Neurobiology of aging 2009;30(8):1184-91.
2009: Deborah Elaine Bauer; Vahram Haroutunian; Robert E McCullumsmith; James H Meador-Woodruff
Expression of four housekeeping proteins in elderly patients with schizophrenia.
Journal of neural transmission (Vienna, Austria : 1996) 2009;116(4):487-91.
2009: Vahram Haroutunian; Pavel Katsel; James Schmeidler
Transcriptional vulnerability of brain regions in Alzheimer's disease and dementia.
Neurobiology of aging 2009;30(4):561-73.
2009: Weiping Qin; Vahram Haroutunian; Pavel Katsel; Christopher P Cardozo; Lap Ho; Joseph Buxbaum; Giulio Maria Pasinetti
PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia.
Archives of neurology 2009;66(3):352-61.
2009: Pasquale G Frisina; Vahram Haroutunian; Leslie S Libow
The neuropathological basis for depression in Parkinson's disease.
Parkinsonism & related disorders 2009;15(2):144-8.
2009: Pavel Katsel; Weilun Tan; Vahram Haroutunian
Gain in brain immunity in the oldest-old differentiates cognitively normal from demented individuals.
PloS one 2009;4(10):e7642.
2009: Michal Schnaider Beeri; Ramit Ravona-Springer; Jeremy Silverman; Vahram Haroutunian
The effects of cardiovascular risk factors on cognitive compromise.
Dialogues in clinical neuroscience 2009;11(2):201-12.
2009: Vahram Haroutunian; Lisa B Hoffman; Michal Schnaider Beeri
Is there a neuropathology difference between mild cognitive impairment and dementia?
Dialogues in clinical neuroscience 2009;11(2):171-9.
2009: Yuji Kajiwara; Afia Akram; Pavel Katsel; Vahram Haroutunian; James Schmeidler; Gary Beecham; Jonathan L Haines; Margaret Pericak-Vance; Joseph Buxbaum
FE65 binds Teashirt, inhibiting expression of the primate-specific caspase-4.
PloS one 2009;4(4):e5071.
2009: Marialaura Amadio; Alessia Pascale; Jun Wang; Lap Ho; Alessandro Quattrone; Sam Gandy; Vahram Haroutunian; Marco Racchi; Giulio Maria Pasinetti
nELAV proteins alteration in Alzheimer's disease brain: a novel putative target for amyloid-beta reverberating on AbetaPP processing.
Journal of Alzheimer's disease : JAD 2009;16(2):409-19.
2009: Gerson T Lesser; Vahram Haroutunian; Dushyant P Purohit; Michal Schnaider Beeri; James Schmeidler; Linda Honkanen; Richard R Neufeld; Leslie S Libow
Serum lipids are related to Alzheimer's pathology in nursing home residents.
Dementia and geriatric cognitive disorders 2009;27(1):42-9.
2008: Mala V Rao; Panaiyur S Mohan; Corrinne M Peterhoff; Dun-Sheng Yang; Stephen D Schmidt; Philip H Stavrides; Jabbar Campbell; Yuanxin Chen; Ying Jiang; Peter A Paskevich; Anne M Cataldo; Vahram Haroutunian; Ralph A. Nixon
Marked calpastatin (CAST) depletion in Alzheimer's disease accelerates cytoskeleton disruption and neurodegeneration: neuroprotection by CAST overexpression.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2008;28(47):12241-54.
2008: Pavel Katsel; Kenneth L Davis; Celeste Li; Weilun Tan; Elizabeth Greenstein; Lisa B Kleiner Hoffman; Vahram Haroutunian
Abnormal indices of cell cycle activity in schizophrenia and their potential association with oligodendrocytes.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(12):2993-3009.
2008: Stella Dracheva; N Patel; D A Woo; Sue M Marcus; Larry J Siever; Vahram Haroutunian
Increased serotonin 2C receptor mRNA editing: a possible risk factor for suicide.
Molecular psychiatry 2008;13(11):1001-10.
2008: Michal Schnaider Beeri; James Schmeidler; Jeremy Silverman; Sam Gandy; M Wysocki; C M Hannigan; Dushyant P Purohit; G Lesser; Hillel T Grossman; Vahram Haroutunian
Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology.
Neurology 2008;71(10):750-7.
2008: Vahram Haroutunian; Michal Schnaider Beeri; James Schmeidler; Michael Wysocki; Dushyant P Purohit; Daniel P Perl; Leslie S Libow; Gerson T Lesser; Maria Maroukian; Hillel T Grossman
Role of the neuropathology of Alzheimer disease in dementia in the oldest-old.
Archives of neurology 2008;65(9):1211-7.
2008: Afia Akram; Daniel Christoffel; Anne B Rocher; Constantin Bouras; Enikö Kövari; Daniel P Perl; John H Morrison; Francois Herrmann; Vahram Haroutunian; Panteleimon Giannakopoulos; Patrick R Hof
Stereologic estimates of total spinophilin-immunoreactive spine number in area 9 and the CA1 field: relationship with the progression of Alzheimer's disease.
Neurobiology of aging 2008;29(9):1296-307.
2008: Gregory A Elder; Andre Ragnauth; Nathan Dorr; Sonia Franciosi; James Schmeidler; Vahram Haroutunian; Joseph Buxbaum
Increased locomotor activity in mice lacking the low-density lipoprotein receptor.
Behavioural brain research 2008;191(2):256-65.
2008: Amy E Steffek; Robert E McCullumsmith; Vahram Haroutunian; James Meador-Woodruff
Cortical expression of glial fibrillary acidic protein and glutamine synthetase is decreased in schizophrenia.
Schizophrenia research 2008;103(1-3):71-82.
2008: Stella Dracheva; William Byne; Benjamin Chin; Vahram Haroutunian
Ionotropic glutamate receptor mRNA expression in the human thalamus: absence of change in schizophrenia.
Brain research 2008;1214():23-34.
2008: David A Baker; Aric Madayag; Lars V Kristiansen; James Meador-Woodruff; Vahram Haroutunian; Ilangovan Raju
Contribution of cystine-glutamate antiporters to the psychotomimetic effects of phencyclidine.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2008;33(7):1760-72.
2008: Akin Oni-Orisan; Lars V Kristiansen; Vahram Haroutunian; James Meador-Woodruff; Robert E McCullumsmith
Altered vesicular glutamate transporter expression in the anterior cingulate cortex in schizophrenia.
Biological psychiatry 2008;63(8):766-75.
2008: Tara Lauriat; Lily Shiue; Vahram Haroutunian; Miguel Verbitsky; Manuel Ares; Luz Ospina; L Alison McInnes
Developmental expression profile of quaking, a candidate gene for schizophrenia, and its target genes in human prefrontal cortex and hippocampus shows regional specificity.
Journal of neuroscience research 2008;86(4):785-96.
2008: Stella Dracheva; Benjamin Chin; Vahram Haroutunian
Altered serotonin 2C receptor RNA splicing in suicide: association with editing.
Neuroreport 2008;19(3):379-82.
2008: Michael A Rapp; Michal Schnaider Beeri; Dushyant P Purohit; Daniel P Perl; Vahram Haroutunian; Mary Sano
Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2008;16(2):168-74.
2008: Raúl Alelú-Paz; Ignacio Iturrieta-Zuazo; William Byne; Vahram Haroutunian; Mercedes García-Villanueva; Alberto Rábano; María García-Amado; Lucía Prensa; José Manuel Giménez-Amaya
A new antigen retrieval technique for human brain tissue.
PloS one 2008;3(10):e3378.
2008: Michal Schnaider Beeri; Jeremy Silverman; James Schmeidler; Michael Wysocki; Hillel Z Grossman; Dushyant P Purohit; Daniel P Perl; Vahram Haroutunian
Clinical dementia rating performed several years prior to death predicts regional Alzheimer's neuropathology.
Dementia and geriatric cognitive disorders 2008;25(5):392-8.
2008: William Byne; Stella Dracheva; Benjamin Chin; James Schmeidler; Kenneth L Davis; Vahram Haroutunian
Schizophrenia and sex associated differences in the expression of neuronal and oligodendrocyte-specific genes in individual thalamic nuclei.
Schizophrenia research 2008;98(1-3):118-28.
2007: Tatiana Yakovleva; Zoya Marinova; Alexander Kuzmin; N G Seidah; Vahram Haroutunian; Lars Terenius; Georgy Bakalkin
Dysregulation of dynorphins in Alzheimer disease.
Neurobiology of aging 2007;28(11):1700-8.
2007: Vahram Haroutunian; Jane Pickett
Autism brain tissue banking.
Brain pathology (Zurich, Switzerland) 2007;17(4):412-21.
2007: Vahram Haroutunian; Kenneth L Davis
Introduction to the special section: Myelin and oligodendrocyte abnormalities in schizophrenia.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2007;10(4):499-502.
2007: Gregory A Elder; Julie Y Cho; Daniel F English; Sonia Franciosi; James Schmeidler; Miguel A Gama Sosa; Rita De Gasperi; Edward A Fisher; Paul Mathews; Vahram Haroutunian; Joseph Buxbaum
Elevated plasma cholesterol does not affect brain Abeta in mice lacking the low-density lipoprotein receptor.
Journal of neurochemistry 2007;102(4):1220-31.
2007: Vahram Haroutunian; Pavel Katsel; Stella Dracheva; Daniel G Stewart; Kenneth L Davis
Variations in oligodendrocyte-related gene expression across multiple cortical regions: implications for the pathophysiology of schizophrenia.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2007;10(4):565-73.
2007: Sandeep K Gill; Margaret Ishak; Tomas Dobransky; Vahram Haroutunian; Kenneth L Davis; Rebecca Rylett
82-kDa choline acetyltransferase is in nuclei of cholinergic neurons in human CNS and altered in aging and Alzheimer disease.
Neurobiology of aging 2007;28(7):1028-40.
2007: Rudy Zhao; Zhongmin Xiang; Vahram Haroutunian; Joseph Buxbaum; Breton Stetka; Giulio Maria Pasinetti
Insulin degrading enzyme activity selectively decreases in the hippocampal formation of cases at high risk to develop Alzheimer's disease.
Neurobiology of aging 2007;28(6):824-30.
2007: Pavel Katsel; Celeste Li; Vahram Haroutunian
Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer's disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer's disease?
Neurochemical research 2007;32(4-5):845-56.
2007: Robert E McCullumsmith; Daya Gupta; Monica Beneyto; Emily Kreger; Vahram Haroutunian; Kenneth L Davis; James Meador-Woodruff
Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia.
Schizophrenia research 2007;90(1-3):15-27.
2007: William Byne; Jason Fernandes; Vahram Haroutunian; Dennis Huacon; Smith Kidkardnee; John Kim; Alex Tatusov; Uma Thakur; Georgia Yiannoulos
Reduction of right medial pulvinar volume and neuron number in schizophrenia.
Schizophrenia research 2007;90(1-3):71-5.
2007: Robert J Greenstein; Liya Su; Vahram Haroutunian; Azra Shahidi; Sheldon Brown
On the action of methotrexate and 6-mercaptopurine on M. avium subspecies paratuberculosis.
PloS one 2007;2(1):e161.
2007: Vahram Haroutunian; Peter Davies; C Vianna; Joseph Buxbaum; Dushyant P Purohit
Tau protein abnormalities associated with the progression of alzheimer disease type dementia.
Neurobiology of aging 2007;28(1):1-7.
2006: Tara Lauriat; Stella Dracheva; Joachim Kremerskothen; Kerstin Duning; Vahram Haroutunian; Joseph Buxbaum; Thomas M Hyde; Joel E Kleinman; L Alison McInnes
Characterization of KIAA0513, a novel signaling molecule that interacts with modulators of neuroplasticity, apoptosis, and the cytoskeleton.
Brain research 2006;1121(1):1-11.
2006: Vahram Haroutunian; Pavel Katsel; Stella Dracheva; Kenneth L Davis
The human homolog of the QKI gene affected in the severe dysmyelination "quaking" mouse phenotype: downregulated in multiple brain regions in schizophrenia.
The American journal of psychiatry 2006;163(10):1834-7.
2006: Karen L Baracskay; Vahram Haroutunian; James Meador-Woodruff
Dopamine receptor signaling molecules are altered in elderly schizophrenic cortex.
Synapse (New York, N.Y.) 2006;60(4):271-9.
2006: Lyudmila Georgieva; Valentina Moskvina; Tim Peirce; Nadine Norton; Nicholas J Bray; Lesley Jones; Peter Holmans; Stuart Macgregor; Stanley Zammit; Jennifer Wilkinson; Hywel Williams; Ivan Nikolov; Nigel Williams; Dobril Ivanov; Kenneth L Davis; Vahram Haroutunian; Joseph Buxbaum; Nick Craddock; George Kirov; Michael J Owen; Michael C O'Donovan
Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(33):12469-74.
2006: Sarah M Clinton; Vahram Haroutunian; James Meador-Woodruff
Up-regulation of NMDA receptor subunit and post-synaptic density protein expression in the thalamus of elderly patients with schizophrenia.
Journal of neurochemistry 2006;98(4):1114-25.
2006: Lars V Kristiansen; Monica Beneyto; Vahram Haroutunian; James Meador-Woodruff
Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia.
Molecular psychiatry 2006;11(8):737-47, 705.
2006: Amy E Steffek; Vahram Haroutunian; James Meador-Woodruff
Serine racemase protein expression in cortex and hippocampus in schizophrenia.
Neuroreport 2006;17(11):1181-5.
2006: D Religa; Dorothea Strozyk; Robert A Cherny; Irene Volitakis; Vahram Haroutunian; Bengt Winblad; J Naslund; Ashley I Bush
Elevated cortical zinc in Alzheimer disease.
Neurology 2006;67(1):69-75.
2006: William Byne; Smith Kidkardnee; Alex Tatusov; Georgia Yiannoulos; Monte Buchsbaum; Vahram Haroutunian
Schizophrenia-associated reduction of neuronal and oligodendrocyte numbers in the anterior principal thalamic nucleus.
Schizophrenia research 2006;85(1-3):245-53.
2006: Ibone Huerta; Robert E McCullumsmith; Vahram Haroutunian; José Manuel Giménez-Amaya; James Meador-Woodruff
Expression of excitatory amino acid transporter interacting protein transcripts in the thalamus in schizophrenia.
Synapse (New York, N.Y.) 2006;59(7):394-402.
2006: Michal Schnaider Beeri; Michael A Rapp; Jeremy Silverman; James Schmeidler; Hillel T Grossman; J T Fallon; Dushyant P Purohit; Daniel P Perl; A Siddiqui; G Lesser; Clive Rosendorff; Vahram Haroutunian
Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers.
Neurology 2006;66(9):1399-404.
2006: Rudy Zhao; Hanna Ksiezak-Reding; Silvana Riggio; Vahram Haroutunian; Giulio Maria Pasinetti
Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction.
Schizophrenia research 2006;84(1):1-14.
2006: Stella Dracheva; Kenneth L Davis; Benjamin Chin; Derek A Woo; James Schmeidler; Vahram Haroutunian
Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients.
Neurobiology of disease 2006;21(3):531-40.
2006: Michael A Rapp; Michal Schnaider Beeri; Hillel T Grossman; Mary Sano; Daniel P Perl; Dushyant P Purohit; Jack M Gorman; Vahram Haroutunian
Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression.
Archives of general psychiatry 2006;63(2):161-7.
2006: Tara Lauriat; Stella Dracheva; Benjamin Chin; James Schmeidler; L Alison McInnes; Vahram Haroutunian
Quantitative analysis of glutamate transporter mRNA expression in prefrontal and primary visual cortex in normal and schizophrenic brain.
Neuroscience 2006;137(3):843-51.
2006: Isak Prohovnik; Daniel P Perl; Kenneth L Davis; Leslie S Libow; G Lesser; Vahram Haroutunian
Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease.
Neurology 2006;66(1):49-55.
2006: Zhongmin Xiang; Vahram Haroutunian; Lap Ho; Dushyant P Purohit; Giulio Maria Pasinetti
Microglia activation in the brain as inflammatory biomarker of Alzheimer's disease neuropathology and clinical dementia.
Disease markers 2006;22(1-2):95-102.
2006: Tim Peirce; Nicholas J Bray; Nigel M Williams; Nadine Norton; Valentina Moskvina; Anna Preece; Vahram Haroutunian; Joseph Buxbaum; Michael J Owen; Michael C O'Donovan
Convergent evidence for 2',3'-cyclic nucleotide 3'-phosphodiesterase as a possible susceptibility gene for schizophrenia.
Archives of general psychiatry 2006;63(1):18-24.
2005: Rudy Zhao; Lap Ho; Jun Wang; Weiping Qin; Eugene D Festa; Charles V Mobbs; Patrick R Hof; Anne B Rocher; Sandra K Masur; Vahram Haroutunian; Giulio Maria Pasinetti
Connective tissue growth factor (CTGF) expression in the brain is a downstream effector of insulin resistance- associated promotion of Alzheimer's disease beta-amyloid neuropathology.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2005;19(14):2081-2.
2005: Pavel Katsel; Kenneth L Davis; Vahram Haroutunian
Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: a gene ontology study.
Schizophrenia research 2005;79(2-3):157-73.
2005: Sarah M Clinton; Hisham M Ibrahim; Kirk A Frey; Kenneth L Davis; Vahram Haroutunian; James Meador-Woodruff
Dopaminergic abnormalities in select thalamic nuclei in schizophrenia: involvement of the intracellular signal integrating proteins calcyon and spinophilin.
The American journal of psychiatry 2005;162(10):1859-71.
2005: Pavel Katsel; Kenneth L Davis; Jack M Gorman; Vahram Haroutunian
Variations in differential gene expression patterns across multiple brain regions in schizophrenia.
Schizophrenia research 2005;77(2-3):241-52.
2005: Daya Shankar Gupta; Robert E McCullumsmith; Monica Beneyto; Vahram Haroutunian; Kenneth L Davis; James Meador-Woodruff
Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia.
Synapse (New York, N.Y.) 2005;57(3):123-31.
2005: Michael A Rapp; Michal Schnaider Beeri; James Schmeidler; Mary Sano; Jeremy Silverman; Vahram Haroutunian
Relationship of neuropsychological performance to functional status in nursing home residents and community-dwelling older adults.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2005;13(6):450-9.
2005: Emile G Bruneau; Robert E McCullumsmith; Vahram Haroutunian; Kenneth L Davis; James Meador-Woodruff
Increased expression of glutaminase and glutamine synthetase mRNA in the thalamus in schizophrenia.
Schizophrenia research 2005;75(1):27-34.
2005: Parvesh Bubber; Vahram Haroutunian; Gene Fisch; John P Blass; Gary Gibson
Mitochondrial abnormalities in Alzheimer brain: mechanistic implications.
Annals of neurology 2005;57(5):695-703.
2005: Michael A Rapp; Michal Schnaider Beeri; Mary Sano; Jeremy Silverman; Vahram Haroutunian
Cross-domain variability of cognitive performance in very old nursing home residents and community dwellers: relationship to functional status.
Gerontology 2005;51(3):206-12.
2005: Michal Schnaider Beeri; Jeremy Silverman; Kenneth L Davis; Deborah B Marin; Hillel Z Grossman; James Schmeidler; Dushyant P Purohit; Daniel P Perl; Michael Davidson; Richard C Mohs; Vahram Haroutunian
Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology.
The journals of gerontology. Series A, Biological sciences and medical sciences 2005;60(4):471-5.
2005: Michael A Rapp; Karen Dahlman; Mary Sano; Hillel T Grossman; Vahram Haroutunian; Jack M Gorman
Neuropsychological differences between late-onset and recurrent geriatric major depression.
The American journal of psychiatry 2005;162(4):691-8.
2005: Stella Dracheva; Susan R McGurk; Vahram Haroutunian
mRNA expression of AMPA receptors and AMPA receptor binding proteins in the cerebral cortex of elderly schizophrenics.
Journal of neuroscience research 2005;79(6):868-78.
2005: Pavel Katsel; Kenneth L Davis; Vahram Haroutunian
Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease.
International review of neurobiology 2005;63():41-82.
2004: Abraham M Brown; Derek Gordon; Hsinhwa Lee; Michael Caudy; John Hardy; Vahram Haroutunian; John P Blass
Association of the dihydrolipoamide dehydrogenase gene with Alzheimer's disease in an Ashkenazi Jewish population.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2004;131B(1):60-6.
2004: Nicholas J Bray; Luke Jehu; Valentina Moskvina; Joseph Buxbaum; Stella Dracheva; Vahram Haroutunian; Julie Williams; Paul R Buckland; Michael J Owen; Michael C O'Donovan
Allelic expression of APOE in human brain: effects of epsilon status and promoter haplotypes.
Human molecular genetics 2004;13(22):2885-92.
2004: Paul R Buckland; Bastiaan Hoogendoorn; Carol A Guy; Sharon L Coleman; S Kaye Smith; Joseph Buxbaum; Vahram Haroutunian; Michael C O'Donovan
A high proportion of polymorphisms in the promoters of brain expressed genes influences transcriptional activity.
Biochimica et biophysica acta 2004;1690(3):238-49.
2004: Anne M Cataldo; Suzana Petanceska; Nicole B Terio; Corrinne M Peterhoff; Robert Durham; Marc Mercken; Pankaj D Mehta; Joseph Buxbaum; Vahram Haroutunian; Ralph A. Nixon
Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome.
Neurobiology of aging 2004;25(10):1263-72.
2004: Jie Bai; Fang He; Svetlana Novikova; Ashiwel S Undieh; Stella Dracheva; Vahram Haroutunian; Michael S Lidow
Abnormalities in the dopamine system in schizophrenia may lie in altered levels of dopamine receptor-interacting proteins.
Biological psychiatry 2004;56(6):427-40.
2004: Paul H Wen; Patrick R Hof; Xiaoping Chen; Karen Gluck; Gregory Austin; Steven G Younkin; Linda Younkin; Rita DeGasperi; Miguel A Gama Sosa; Nikolaos K Robakis; Vahram Haroutunian; Gregory A Elder
The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult mice.
Experimental neurology 2004;188(2):224-37.
2004: Stella Dracheva; Sharif L Elhakem; Susan R McGurk; Kenneth L Davis; Vahram Haroutunian
GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia.
Journal of neuroscience research 2004;76(4):581-92.
2004: Abraham M Brown; Derek Gordon; Hsinhwa Lee; Michael Caudy; Vahram Haroutunian; John P Blass
Substantial linkage disequilibrium across the dihydrolipoyl succinyltransferase gene region without Alzheimer's disease association.
Neurochemical research 2004;29(3):629-35.
2004: Helena T Mueller; Vahram Haroutunian; Kenneth L Davis; James Meador-Woodruff
Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia.
Brain research. Molecular brain research 2004;121(1-2):60-9.
2004: Derek Gordon; Yaning Yang; Chad Haynes; Stephen J Finch; Nancy R Mendell; Abraham M Brown; Vahram Haroutunian
Increasing power for tests of genetic association in the presence of phenotype and/or genotype error by use of double-sampling.
Statistical applications in genetics and molecular biology 2004;3():Article26.
2004: Parvesh Bubber; Jicheng Tang; Vahram Haroutunian; Hui Xu; Kenneth L Davis; John P Blass; Gary Gibson
Mitochondrial enzymes in schizophrenia.
Journal of molecular neuroscience : MN 2004;24(2):315-21.
2004: Anthony C Santucci; Vahram Haroutunian
p-Chloroamphetamine blocks physostigmine-induced memory enhancement in rats with unilateral nucleus basalis lesions.
Pharmacology, biochemistry, and behavior 2004;77(1):59-67.
2003: Stella Dracheva; Sharif L Elhakem; Sue M Marcus; Larry J Siever; Susan R McGurk; Vahram Haroutunian
RNA editing and alternative splicing of human serotonin 2C receptor in schizophrenia.
Journal of neurochemistry 2003;87(6):1402-12.
2003: Meredith Halks-Miller; Miriam L Schroeder; Vahram Haroutunian; Ursula Moenning; Michael Rossi; Cristian L Achim; Dushyant Purohit; Mithra Mahmoudi; Richard Horuk
CCR1 is an early and specific marker of Alzheimer's disease.
Annals of neurology 2003;54(5):638-46.
2003: Christina Lilliehook; Ozlem Bozdagi; Jun Yao; Manuel Gomez-Ramirez; Neeha Zaidi; Wilma Wasco; Sam Gandy; Anthony C Santucci; Vahram Haroutunian; George W Huntley; Joseph Buxbaum
Altered Abeta formation and long-term potentiation in a calsenilin knock-out.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(27):9097-106.
2003: Mirsada Causevic; Nicolas Ramoz; Vahram Haroutunian; Kenneth L Davis; Joseph Buxbaum
Lack of association between the levels of the low-density lipoprotein receptor-related protein (LRP) and either Alzheimer dementia or LRP exon 3 genotype.
Journal of neuropathology and experimental neurology 2003;62(10):999-1005.
2003: Oksana Polesskaya; Vahram Haroutunian; Kenneth L Davis; Ivan Hernandez; Boris P Sokolov
Novel putative nonprotein-coding RNA gene from 11q14 displays decreased expression in brains of patients with schizophrenia.
Journal of neuroscience research 2003;74(1):111-22.
2003: Kenneth L Davis; Vahram Haroutunian
Global expression-profiling studies and oligodendrocyte dysfunction in schizophrenia and bipolar disorder.
Lancet 2003;362(9386):758.
2003: Patrick R Hof; Vahram Haroutunian; Victor L Friedrich; William Byne; Cristian Buitron; Daniel P Perl; Kenneth L Davis
Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia.
Biological psychiatry 2003;53(12):1075-85.
2003: Sarah M Clinton; Vahram Haroutunian; Kenneth L Davis; James Meador-Woodruff
Altered transcript expression of NMDA receptor-associated postsynaptic proteins in the thalamus of subjects with schizophrenia.
The American journal of psychiatry 2003;160(6):1100-9.
2003: Kenneth L Davis; Daniel G Stewart; Joseph I Friedman; Monte Buchsbaum; Philip D Harvey; Patrick R Hof; Joseph Buxbaum; Vahram Haroutunian
White matter changes in schizophrenia: evidence for myelin-related dysfunction.
Archives of general psychiatry 2003;60(5):443-56.
2003: Dorota Religa; Hanna Laudon; Maria Styczynska; Bengt Winblad; Jan Näslund; Vahram Haroutunian
Amyloid beta pathology in Alzheimer's disease and schizophrenia.
The American journal of psychiatry 2003;160(5):867-72.
2003: Michael Serby; Adam Brickman; Vahram Haroutunian; Dushyant P Purohit; Deborah B Marin; Melinda Lantz; Richard C Mohs; Kenneth L Davis
Cognitive burden and excess Lewy-body pathology in the Lewy-body variant of Alzheimer disease.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2003;11(3):371-4.
2003: Patrick N Pompl; Shrishailam Yemul; Zhongmin Xiang; Lap Ho; Vahram Haroutunian; Dushyant P Purohit; Richard C Mohs; Giulio Maria Pasinetti
Caspase gene expression in the brain as a function of the clinical progression of Alzheimer disease.
Archives of neurology 2003;60(3):369-76.
2002: Patrick R Hof; Vahram Haroutunian; Christina Copland; Kenneth L Davis; Joseph Buxbaum
Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia.
Neurochemical research 2002;27(10):1193-200.
2002: Tada Utsuki; Mohammed Shoaib; Harold W Holloway; Donald Ingram; William C Wallace; Vahram Haroutunian; Kumar Sambamurti; Debomoy K Lahiri; Nigel H Greig
Nicotine lowers the secretion of the Alzheimer's amyloid beta-protein precursor that contains amyloid beta-peptide in rat.
Journal of Alzheimer's disease : JAD 2002;4(5):405-15.
2002: Vahram Haroutunian; Kenneth L Davis
Issues and perspectives on brain tissue banking.
Current psychiatry reports 2002;4(4):233-4.
2002: Martin R Gluck; Rohan G Thomas; Kenneth L Davis; Vahram Haroutunian
Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients.
The American journal of psychiatry 2002;159(7):1165-73.
2002: William Byne; Monte Buchsbaum; Linda A Mattiace; Erin A Hazlett; Eileen M Kemether; Sharif L Elhakem; Dushyant P Purohit; Vahram Haroutunian; Liesl Jones
Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia.
The American journal of psychiatry 2002;159(1):59-65.
2001: S Parvathy; Peter Davies; Vahram Haroutunian; Dushyant P Purohit; Kenneth L Davis; Richard C Mohs; H Park; Thomas M Moran; J Y Chan; Joseph Buxbaum
Correlation between Abetax-40-, Abetax-42-, and Abetax-43-containing amyloid plaques and cognitive decline.
Archives of neurology 2001;58(12):2025-32.
2001: R E Smith; Vahram Haroutunian; Kenneth L Davis; James Meador-Woodruff
Vesicular glutamate transporter transcript expression in the thalamus in schizophrenia.
Neuroreport 2001;12(13):2885-7.
2001: Stella Dracheva; Salvatore A E Marras; Sharif L Elhakem; Fred Kramer; Kenneth L Davis; Vahram Haroutunian
N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia.
The American journal of psychiatry 2001;158(9):1400-10.
2001: R E Smith; Vahram Haroutunian; Kenneth L Davis; James Meador-Woodruff
Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia.
The American journal of psychiatry 2001;158(9):1393-9.
2001: Stella Dracheva; Vahram Haroutunian
Locomotor behavior of dopamine D1 receptor transgenic/D2 receptor deficient hybrid mice.
Brain research 2001;905(1-2):142-51.
2001: James Meador-Woodruff; Kenneth L Davis; Vahram Haroutunian
Abnormal kainate receptor expression in prefrontal cortex in schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;24(5):545-52.
2001: Yaron Hakak; John R Walker; C Li; W H Wong; Kenneth L Davis; Joseph Buxbaum; Vahram Haroutunian; Allen Fienberg
Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(8):4746-51.
2001: Lap Ho; Dushyant P Purohit; Vahram Haroutunian; JD Luterman; F Willis; J Naslund; Joseph Buxbaum; Richard C Mohs; Paul S Aisen; Giulio Maria Pasinetti
Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease.
Archives of neurology 2001;58(3):487-92.
2001: G Lesser; K Kandiah; Leslie S Libow; Antonios Likourezos; Brenda Breuer; Deborah B Marin; Richard C Mohs; Vahram Haroutunian; Richard R Neufeld
Elevated serum total and LDL cholesterol in very old patients with Alzheimer's disease.
Dementia and geriatric cognitive disorders 2001;12(2):138-45.
2001: Lap Ho; Y Guo; Lauren Spielman; O Petrescu; Vahram Haroutunian; Dushyant P Purohit; A Czernik; Shrishailam Yemul; Paul S Aisen; Richard C Mohs; Giulio Maria Pasinetti
Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray technique.
Neuroscience letters 2001;298(3):191-4.
2001: A M Brown; RK Sheu; Richard C Mohs; Vahram Haroutunian; John P Blass
Correlation of the clinical severity of Alzheimer's disease with an aberration in mitochondrial DNA (mtDNA).
Journal of molecular neuroscience : MN 2001;16(1):41-8.
2000: Hisham M Ibrahim; AJ Hogg; Daniel J Healy; Vahram Haroutunian; Kenneth L Davis; James Meador-Woodruff
Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia.
The American journal of psychiatry 2000;157(11):1811-23.
2000: Gary Gibson; Vahram Haroutunian; H Zhang; Larry C H Park; Qingli Shi; M Lesser; Richard C Mohs; RK Sheu; John P Blass
Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype.
Annals of neurology 2000;48(3):297-303.
2000: JD Luterman; Vahram Haroutunian; Shrishailam Yemul; Lap Ho; Dushyant P Purohit; Paul S Aisen; Richard C Mohs; Giulio Maria Pasinetti
Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia.
Archives of neurology 2000;57(8):1153-60.
2000: Vahram Haroutunian; Michael Serby; Dushyant P Purohit; Daniel P Perl; Deborah B Marin; Melinda Lantz; Richard C Mohs; Kenneth L Davis
Contribution of Lewy body inclusions to dementia in patients with and without Alzheimer disease neuropathological conditions.
Archives of neurology 2000;57(8):1145-50.
2000: Boris P Sokolov; A A Tcherepanov; Vahram Haroutunian; Kenneth L Davis
Levels of mRNAs encoding synaptic vesicle and synaptic plasma membrane proteins in the temporal cortex of elderly schizophrenic patients.
Biological psychiatry 2000;48(3):184-96.
2000: Philip D Harvey; H Jacobsen; D Mancini; Michael Parrella; Leonard White; Vahram Haroutunian; Kenneth L Davis
Clinical, cognitive and functional characteristics of long-stay patients with schizophrenia: a comparison of VA and state hospital patients.
Schizophrenia research 2000;43(1):3-9.
2000: Elaine K Perry; Carmen Martin-Ruiz; M Lee; M Griffiths; M Johnson; Margaret A Piggott; Vahram Haroutunian; Joseph Buxbaum; J Nãsland; Kenneth L Davis; Cecilia Gotti; Francesco Clementi; S Tzartos; O Cohen; H Soreq; Evelyn Jaros; Robert H Perry; Clive G Ballard; Ian G McKeith; Jennifer A Court
Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases.
European journal of pharmacology 2000;393(1-3):215-22.
2000: J Näslund; Vahram Haroutunian; Richard C Mohs; Kenneth L Davis; Peter Davies; Paul Greengard; Joseph Buxbaum
Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline.
JAMA : the journal of the American Medical Association 2000;283(12):1571-7.
2000: M R Gluck; E Jayatilleke; S Shaw; A J Rowan; Vahram Haroutunian
CNS oxidative stress associated with the kainic acid rodent model of experimental epilepsy.
Epilepsy research 2000;39(1):63-71.
2000: Sarah M Richardson-Burns; Vahram Haroutunian; Kenneth L Davis; Stanley J Watson Jr; James Meador-Woodruff
Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamus.
Biological psychiatry 2000;47(1):22-8.
2000: Gunnar K Gouras; J Tsai; J Naslund; B Vincent; Mark A Edgar; F Checler; Jeffrey P Greenfield; Vahram Haroutunian; Joseph Buxbaum; Huaxi Xu; Paul Greengard; Norman Richard Relkin
Intraneuronal Abeta42 accumulation in human brain.
The American journal of pathology 2000;156(1):15-20.
1999: Kenneth L Davis; Richard C Mohs; Deborah B Marin; Dushyant P Purohit; Daniel P Perl; Melinda Lantz; G Austin; Vahram Haroutunian
Neuropeptide abnormalities in patients with early Alzheimer disease.
Archives of general psychiatry 1999;56(11):981-7.
1999: Vahram Haroutunian; Dushyant P Purohit; Daniel P Perl; Deborah B Marin; K Khan; Melinda Lantz; Kenneth L Davis; Richard C Mohs
Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease.
Archives of neurology 1999;56(6):713-8.
1999: Stella Dracheva; M Xu; Kevin A Kelley; Vahram Haroutunian; Gay Robbins Holstein; S Haun; J H Silverstein; Stuart C Sealfon
Paradoxical locomotor behavior of dopamine D1 receptor transgenic mice.
Experimental neurology 1999;157(1):169-79.
1999: Kenneth L Davis; Richard C Mohs; Deborah B Marin; Dushyant P Purohit; Daniel P Perl; Melinda Lantz; G Austin; Vahram Haroutunian
Cholinergic markers in elderly patients with early signs of Alzheimer disease.
JAMA : the journal of the American Medical Association 1999;281(15):1401-6.
1999: Batia Kaplan; Vahram Haroutunian; A Koudinov; Y Patael; Mordechai Pras; G Gallo
Biochemical assay for amyloid beta deposits to distinguish Alzheimer's disease from other dementias.
Clinica chimica acta; international journal of clinical chemistry 1999;280(1-2):147-59.
1999: KF Sheu; Abraham M Brown; Vahram Haroutunian; Bruce Kristal; Howard T Thaler; M Lesser; Rajesh N. Kalaria; N R Relkin; Richard C Mohs; L Lilius; Lars Lannfelt; John P Blass
Modulation by DLST of the genetic risk of Alzheimer's disease in a very elderly population.
Annals of neurology 1999;45(1):48-53.
1998: Daniel J Healy; Vahram Haroutunian; P Powchik; M Davidson; Kenneth L Davis; Stanley J Watson Jr; James Meador-Woodruff
AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1998;19(4):278-86.
1998: Hady Shimon; Y Sobolev; M Davidson; Vahram Haroutunian; Robert H Belmaker; Galila Agam
Inositol levels are decreased in postmortem brain of schizophrenic patients.
Biological psychiatry 1998;44(6):428-32.
1998: Vahram Haroutunian; Daniel P Perl; Dushyant P Purohit; Deborah B Marin; K Khan; Melinda Lantz; Kenneth L Davis; Richard C Mohs
Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease.
Archives of neurology 1998;55(9):1185-91.
1998: Dushyant P Purohit; Daniel P Perl; Vahram Haroutunian; Peter Powchik; Michael Davidson; Kenneth L Davis
Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases.
Archives of general psychiatry 1998;55(3):205-11.
1998: Peter Powchik; Michael Davidson; Vahram Haroutunian; SM Gabriel; Dushyant P Purohit; Daniel P Perl; Philip D Harvey; Kenneth L Davis
Postmortem studies in schizophrenia.
Schizophrenia bulletin 1998;24(3):325-41.
1998: H Reznik-Wolf; J Machado; Vahram Haroutunian; L DeMarco; G F Walter; B Goldman; M Davidson; J A Johnston; Lars Lannfelt; Sergio Dani; Eitan Friedman
Somatic mutation analysis of the APP and Presenilin 1 and 2 genes in Alzheimer's disease brains.
Journal of neurogenetics 1998;12(1):55-65.
1997: James Meador-Woodruff; Vahram Haroutunian; P Powchik; M Davidson; Kenneth L Davis; Stanley J Watson Jr
Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia.
Archives of general psychiatry 1997;54(12):1089-95.
1997: Peter Powchik; J Friedman; Vahram Haroutunian; D Greenberg; L Altsteil; Dushyant P Purohit; Daniel P Perl; Michael Davidson
Apolipoprotein E4 in schizophrenia: a study of one hundred sixteen cases with concomitant neuropathological examination.
Biological psychiatry 1997;42(4):296-8.
1997: SM Gabriel; Vahram Haroutunian; Peter Powchik; William Honer; Michael Davidson; Peter Davies; Kenneth L Davis
Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia.
Archives of general psychiatry 1997;54(6):559-66.
1997: Vahram Haroutunian; Nigel H Greig; X F Pei; Tada Utsuki; R Gluck; L D Acevedo; Kenneth L Davis; William C Wallace
Pharmacological modulation of Alzheimer's beta-amyloid precursor protein levels in the CSF of rats with forebrain cholinergic system lesions.
Brain research. Molecular brain research 1997;46(1-2):161-8.
1997: G Li; M Aryan; Jeremy Silverman; Vahram Haroutunian; Daniel P Perl; S Birstein; Melinda Lantz; Deborah B Marin; Richard C Mohs; Kenneth L Davis
The validity of the family history method for identifying Alzheimer disease.
Archives of neurology 1997;54(5):634-40.
1996: Vahram Haroutunian; Y Zhou; Gregory A Elder; C Li; Robert A Lazzarini
Age-dependent spatial memory deficits in transgenic mice expressing the human mid-sized neurofilament gene: I.
Brain research. Molecular brain research 1996;42(1):62-70.
1996: James Meador-Woodruff; S P Damask; J Wang; Vahram Haroutunian; Kenneth L Davis; Stanley J Watson Jr
Dopamine receptor mRNA expression in human striatum and neocortex.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1996;15(1):17-29.
1996: J T Klein; L Davis; G E Olsen; G S Wong; F P Huger; C P Smith; W W Petko; M Cornfeldt; J C Wilker; R D Blitzer; E Landau; Vahram Haroutunian; L L Martin; R C Effland
Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.
Journal of medicinal chemistry 1996;39(2):570-81.
1996: S M Gabriel; Michael Davidson; Vahram Haroutunian; Peter Powchik; L M Bierer; Dushyant P Purohit; Daniel P Perl; Kenneth L Davis
Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex.
Biological psychiatry 1996;39(2):82-91.
1996: A C Santucci; PJ Knott; Vahram Haroutunian
Excessive serotonin release, not depletion, leads to memory impairments in rats.
European journal of pharmacology 1996;295(1):7-17.
1996: G Li; Jeremy Silverman; L D Altstiel; Vahram Haroutunian; Daniel P Perl; Dushyant P Purohit; S Birstein; Melinda Lantz; Richard C Mohs; Kenneth L Davis
Apolipoprotein E-epsilon 4 allele and familial risk in Alzheimer's disease.
Genetic epidemiology 1996;13(3):285-98.
1995: S M Gabriel; PJ Knott; Vahram Haroutunian
Alterations in cerebral cortical galanin concentrations following neurotransmitter-specific subcortical lesions in the rat.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1995;15(8):5526-34.
1995: W C Wallace; I Lieberburg; Dale Schenk; C Vigo-Pelfrey; Kenneth L Davis; Vahram Haroutunian
Chronic elevation of secreted amyloid precursor protein in subcortically lesioned rats, and its exacerbation in aged rats.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1995;15(7 Pt 1):4896-905.
1995: A C Santucci; P D Kanof; Vahram Haroutunian
Transient enhancement of cholinergic neurochemical markers induced by NGF in aged F344 rats.
Dementia (Basel, Switzerland) 1995;6(4):179-84.
1995: Brian A Lawlor; T M Ryan; L M Bierer; James Schmeidler; Vahram Haroutunian; Richard C Mohs; Kenneth L Davis
Lack of association between clinical symptoms and postmortem indices of brain serotonin function in Alzheimer's disease.
Biological psychiatry 1995;37(12):895-6.
1995: L M Bierer; Vahram Haroutunian; S Gabriel; PJ Knott; L S Carlin; Dushyant P Purohit; Daniel P Perl; James Schmeidler; P Kanof; Kenneth L Davis
Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits.
Journal of neurochemistry 1995;64(2):749-60.
1995: Myron Miller; Vahram Haroutunian; M Wiltshire-Clement
Altered alertness of vasopressin-secreting transgenic mice.
Peptides 1995;16(8):1329-33.
1994: Vahram Haroutunian; Michael Davidson; P D Kanof; Daniel P Perl; Peter Powchik; M Losonczy; J McCrystal; Dushyant P Purohit; L M Bierer; Kenneth L Davis
Cortical cholinergic markers in schizophrenia.
Schizophrenia research 1994;12(2):137-44.
1994: Elaine K Perry; Vahram Haroutunian; Kenneth L Davis; R Levy; P Lantos; S Eagger; Mrinalini Honavar; A Dean; M Griffiths; Ian G McKeith
Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease.
Neuroreport 1994;5(7):747-9.
1994: W Wallace; D Brane; N Hsu; N Khowong; Carl R Merril; Vahram Haroutunian
Characterization of gene expression in the cerebral cortices of rat brains containing subcortical lesions.
Applied and theoretical electrophoresis : the official journal of the International Electrophoresis Society 1994;4(1):33-8.
1993: L M Bierer; PJ Knott; James Schmeidler; Deborah B Marin; T M Ryan; Vahram Haroutunian; Dushyant P Purohit; Daniel P Perl; Richard C Mohs; Kenneth L Davis
Post-mortem examination of dopaminergic parameters in Alzheimer's disease: relationship to noncognitive symptoms.
Psychiatry research 1993;49(3):211-7.
1993: W Wallace; Vahram Haroutunian
Using the subcortically lesioned rat cortex to understand the physiological role of amyloid precursor protein.
Behavioural brain research 1993;57(2):199-206.
1993: Peter Powchik; Michael Davidson; Charles Nemeroff; Vahram Haroutunian; Dushyant P Purohit; M Losonczy; Garth Bissette; Daniel P Perl; H Ghanbari; B Miller
Alzheimer's-disease-related protein in geriatric schizophrenic patients with cognitive impairment.
The American journal of psychiatry 1993;150(11):1726-7.
1993: Claudia Schmauss; Vahram Haroutunian; Kenneth L Davis; Michael Davidson
Selective loss of dopamine D3-type receptor mRNA expression in parietal and motor cortices of patients with chronic schizophrenia.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(19):8942-6.
1993: W Wallace; S T Ahlers; J Gotlib; V Bragin; J Sugar; R Gluck; P A Shea; Kenneth L Davis; Vahram Haroutunian
Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(18):8712-6.
1993: A C Santucci; R Gluck; P D Kanof; Vahram Haroutunian
Induction of memory and cortical cholinergic neurochemical recovery with combine fetal transplantation and GM1 treatments in rats with lesions of the NBM.
Dementia (Basel, Switzerland) 1993;4(5):273-81.
1993: A C Santucci; P D Kanof; Vahram Haroutunian
Cholinergic marker deficits induced by lesions of the nucleus basalis of Meynert are attenuated by nerve growth factor in young, but not in aged, F344 rats.
Brain research 1993;609(1-2):327-32.
1993: Dushyant P Purohit; Michael Davidson; Daniel P Perl; Peter Powchik; Vahram Haroutunian; L M Bierer; J McCrystal; M Losonczy; Kenneth L Davis
Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study.
Biological psychiatry 1993;33(4):255-60.
1992: G Johnson; J Gotlib; Vahram Haroutunian; L Bierer; Angus Nairn; Carl R Merril; W Wallace
Increased phosphorylation of elongation factor 2 in Alzheimer's disease.
Brain research. Molecular brain research 1992;15(3-4):319-26.
1991: N Perez; J Sugar; S Charya; G Johnson; Carl R Merril; L Bierer; Daniel P Perl; Vahram Haroutunian; W Wallace
Increased synthesis and accumulation of heat shock 70 proteins in Alzheimer's disease.
Brain research. Molecular brain research 1991;11(3-4):249-54.
1991: W C Wallace; V Bragin; Nikolaos K Robakis; Kumar Sambamurti; Dale VanderPutten; Carl R Merril; Kenneth L Davis; A C Santucci; Vahram Haroutunian
Increased biosynthesis of Alzheimer amyloid precursor protein in the cerebral cortex of rats with lesions of the nucleus basalis of Meynert.
Brain research. Molecular brain research 1991;10(2):173-8.
1991: A C Santucci; Vahram Haroutunian; Kenneth L Davis
Pharmacological alleviation of combined cholinergic/noradrenergic lesion-induced memory deficits in rats.
Clinical neuropharmacology 1991;14 Suppl 1():S1-8.
1991: A C Santucci; P D Kanof; Vahram Haroutunian
Fetal transplant-induced restoration of spatial memory in rats with lesions of the nucleus basalis of Meynert.
Journal of neural transplantation & plasticity 1991;2(1):65-74.
1991: K M Parks; J E Sugar; Vahram Haroutunian; L Bierer; Daniel P Perl; W C Wallace
Reduced in vitro phosphorylation of synapsin I (site 1) in Alzheimer's disease postmortem tissues.
Brain research. Molecular brain research 1991;9(1-2):125-34.
1990: Vahram Haroutunian; P D Kanof; G Tsuboyama; Kenneth L Davis
Restoration of cholinomimetic activity by clonidine in cholinergic plus noradrenergic lesioned rats.
Brain research 1990;507(2):261-6.
1990: L M Bierer; Daniel P Perl; Vahram Haroutunian; Richard C Mohs; Kenneth L Davis
Neurofibrillary tangles, Alzheimer's disease and Lewy bodies.
Lancet 1990;335(8682):163.
1990: Vahram Haroutunian; R Mantin; P D Kanof
Frontal cortex as the site of action of physostigmine in nbM-lesioned rats.
Physiology & behavior 1990;47(1):203-6.
1990: Vahram Haroutunian; A C Santucci; Kenneth L Davis
Implications of multiple transmitter system lesions for cholinomimetic therapy in Alzheimer's disease.
Progress in brain research 1990;84():333-46.
1989: J P Anderson; Lorenzo M Refolo; W Wallace; P Mehta; M Krishnamurthi; J Gotlib; L Bierer; Vahram Haroutunian; Daniel P Perl; Nikolaos K Robakis
Differential brain expression of the Alzheimer's amyloid precursor protein.
The EMBO journal 1989;8(12):3627-32.
1989: Vahram Haroutunian; P D Kanof; Kenneth L Davis
Interactions of forebrain cholinergic and somatostatinergic systems in the rat.
Brain research 1989;496(1-2):98-104.
1989: G M Shutske; F A Pierrat; K J Kapples; M L Cornfeldt; M R Szewczak; F P Huger; G M Bores; Vahram Haroutunian; Kenneth L Davis
9-Amino-1,2,3,4-tetrahydroacridin-1-ols: synthesis and evaluation as potential Alzheimer's disease therapeutics.
Journal of medicinal chemistry 1989;32(8):1805-13.
1989: A C Santucci; P D Kanof; Vahram Haroutunian
Infusion of NMDA into the nucleus basalis of Meynert, frontal cortex or lateral ventricle in rats: effect on memory and cholinergic brain neurochemistry.
Pharmacology, biochemistry, and behavior 1989;33(2):485-8.
1989: Vahram Haroutunian; P D Kanof; Kenneth L Davis
Attenuation of nucleus basalis of Meynert lesion-induced cholinergic deficits by nerve growth factor.
Brain research 1989;487(1):200-3.
1989: A C Santucci; Vahram Haroutunian
Nucleus basalis lesions impair memory in rats trained on nonspatial and spatial discrimination tasks.
Physiology & behavior 1989;45(5):1025-31.
1989: D M Benson; Robert Blitzer; Vahram Haroutunian; E M Landau
Functional muscarinic supersensitivity in denervated rat hippocampus.
Brain research 1989;478(2):399-402.
1989: J Anderson; W Wallace; S Snyder; Vahram Haroutunian; James Roberts; I Lieberburg
Cellular forms of the rat and human beta-amyloid precursor protein (BAPP).
Brain research 1989;478(2):391-8.
1989: A C Santucci; Vahram Haroutunian; G K Tsuboyama; P D Kanof; Kenneth L Davis
Therapeutics of Alzheimer's disease for clinical and pre-clinical issues.
Progress in clinical and biological research 1989;317():1111-20.
1989: A C Santucci; P D Kanof; Vahram Haroutunian
Effect of physostigmine on memory consolidation and retrieval processes in intact and nucleus basalis-lesioned rats.
Psychopharmacology 1989;99(1):70-4.
1988: G M Shutske; F A Pierrat; M L Cornfeldt; M R Szewczak; F P Huger; G M Bores; Vahram Haroutunian; Kenneth L Davis
(+/-)-9-Amino-1,2,3,4-tetrahydroacridin-1-ol. A potential Alzheimer's disease therapeutic of low toxicity.
Journal of medicinal chemistry 1988;31(7):1278-9.
1988: Vahram Haroutunian; P Knott; Kenneth L Davis
Effects of mesocortical dopaminergic lesions upon subcortical dopaminergic function.
Psychopharmacology bulletin 1988;24(3):341-4.
1987: Vahram Haroutunian; R Mantin; G A Campbell; G K Tsuboyama; Kenneth L Davis
Cysteamine-induced depletion of central somatostatin-like immunoactivity: effects on behavior, learning, memory and brain neurochemistry.
Brain research 1987;403(2):234-42.
1986: Vahram Haroutunian; P D Kanof; G K Tsuboyama; G A Campbell; Kenneth L Davis
Animal models of Alzheimer's disease: behavior, pharmacology, transplants.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1986;13(4 Suppl):385-93.
1986: Vahram Haroutunian; P D Kanof; Kenneth L Davis
Partial reversal of lesion-induced deficits in cortical cholinergic markers by nerve growth factor.
Brain research 1986;386(1-2):397-9.
1985: Vahram Haroutunian; P Kanof; Kenneth L Davis
Pharmacological alleviation of cholinergic lesion induced memory deficits in rats.
Life sciences 1985;37(10):945-52.
1985: Vahram Haroutunian; E Barnes; Kenneth L Davis
Cholinergic modulation of memory in rats.
Psychopharmacology 1985;87(3):266-71.
1983: B A Campbell; Vahram Haroutunian
Perceptual sharpening in the developing rat.
Journal of comparative psychology (Washington, D.C. : 1983) 1983;97(1):3-11.
1982: Vahram Haroutunian; B A Campbell
Neural control of the heart-rate-orienting response in preweanling rats.
Behavioral and neural biology 1982;36(1):24-39.
1981: B A Campbell; Vahram Haroutunian
Effects of age on long-term memory: retention of fixed interval responding.
Journal of gerontology 1981;36(3):338-41.
1981: Vahram Haroutunian; B A Campbell
Development and habituation of the heart rate orienting response to auditory and visual stimuli in the rat.
Journal of comparative and physiological psychology 1981;95(1):166-74.
1980: D J Stehouwer; Vahram Haroutunian; B A Campbell
Generalization of habituation to electrical stimulation of the forelimb in neonatal and preweanling rats.
Behavioral and neural biology 1980;29(2):203-15.
1979: Vahram Haroutunian; B A Campbell
Emergence of interoceptive and exteroceptive control of behavior in rats.
Science (New York, N.Y.) 1979;205(4409):927-9.
1979: Vahram Haroutunian; david riccio
Age-dependent effects of preconditioning aversive experiences on the retention of conditioned fear in weanling rats.
Behavioral and neural biology 1979;26(2):248-53.
1979: Vahram Haroutunian; david riccio
Reduction of ontogenetic retention decrements in rats by pretraining stressful experiences.
Journal of comparative and physiological psychology 1979;93(3):501-11.
1979: Vahram Haroutunian; david riccio
Drug-induced "arousal" and the effectiveness of CS exposure in the reinstatement of memory.
Behavioral and neural biology 1979;26(1):115-20.
1977: Vahram Haroutunian; david riccio
Effect of arousal conditions during reinstatement treatment upon learned fear in young rats.
Developmental psychobiology 1977;10(1):25-32.